Table 2 Demographic and baseline characteristics, and history of LT
| Â | Females | Males | Total |
|---|---|---|---|
(n = 177) | (n = 561) | (n = 738) | |
Age (years) at LT, mean (SD) | 50.8 (12.2) | 53.8 (8.5) | 53.1 (9.6) |
Age (years) at inclusion visit, mean (SD) | 53.2 (12.2) | 56.2 (8.5) | 55.5 (9.7) |
BMI 6 months after LT, mean (SD) | 24.0 (4.1) | 25.0 (3.1) | 24.8 (3.4) |
BMI at inclusion visit, mean (SD) | 25.2 (4.5) | 26.1 (3.3) | 25.8 (3.7) |
BMI at follow-up visit, mean (SD) | 25.7 (4.9) | 26.4 (3.5) | 26.2 (3.9) |
Time (months) from liver transplant to inclusion visit, mean (SD) | 29.1 (16.1) | 28.9 (16.3) | 29.0 (16.2) |
Time (months) from liver transplant to inclusion visit by class | |||
 [5 months; 1 year) | 31 (17.5%) | 97 (17.3%) | 128 (17.3%) |
 [1 year; 2 years) | 46 (26.0%) | 158 (28.2%) | 204 (27.6%) |
 [2 years; 3 years) | 38 (21.5%) | 105 (18.7%) | 143 (19.4%) |
 [3 years; 4 years) | 31 (17.5%) | 108 (19.3%) | 139 (18.8%) |
 [4 years; 5.5 years] | 31 (17.5%) | 93 (16.6%) | 124 (16.8%) |
MELD score at transplant, mean (SD) | 18.2 (8.4) | 17.47 (7.1) | 17.7 (7.4) |
MELD score at transplant by class, N (%) | |||
 Low MELD (<=14) | 54 (36.2%) | 196 (41.4%) | 250 (40.2%) |
 Intermediate MELD (15–24) | 65 (43.6%) | 208 (44.0%) | 273 (43.9%) |
 High MELD (> = 25) | 30 (20.1%) | 69 (14.6%) | 99 (15.9%) |
 NA | 13 | 38 | 51 |
 Not Recorded | 15 | 50 | 65 |
Main conditions leading to LT (> 10%), N (%) | |||
 Hepatocellular carcinoma in cirrhotic liver + cirrhosis, HCV+ | 27 (15.3%) | 143 (25.5%) | 170 (23.0%) |
 Hepatocellular carcinoma in cirrhotic liver + cirrhosis, HCV- | 15 (8.5%) | 110 (19.6%) | 125 (17.0%) |
 Cirrhosis, HCV+ | 23 (13.0%) | 120 (21.4%) | 143 (19.4%) |
 Cirrhosis, HCV- | 70 (39.6%) | 149 (26.6%) | 219 (29.7%) |
HCV+ and HBV+ patients having hepatocellular carcinoma in hepatic liver or cirrhosis as disease leading to liver transplantation | |||
 HBV+ | 34 (19.2%) | 137 (24.4%) | 171 (23.2%) |
 HCV+ | 51 (28.8%) | 266 (47.4%) | 317 (43.0%) |